Loading...

Bone Biologics Corporation

BBLGWNASDAQ
Healthcare
Medical - Devices
$15.00
$0.00(0.00%)

Bone Biologics Corporation BBLGW Peers

See (BBLGW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BBLGW$15.00+0.00%8.2M-104.17-$0.14N/A
ABT$134.11+0.00%233.9B17.48$7.69+1.70%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$103.63+0.00%154.3B76.15$1.37N/A
SYK$391.81+0.00%151.1B53.49$7.39+0.84%
MDT$88.28+0.00%113.3B24.48$3.61+3.18%
EW$77.02+0.00%45B31.73$2.42N/A
DXCM$83.58+0.00%32.5B62.35$1.33N/A
STE$238.25+0.00%23.4B38.56$6.16+0.96%
PHG$24.52+0.00%22.4B80.57$0.30+3.67%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BBLGW vs ABT Comparison

BBLGW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BBLGW stands at 8.2M. In comparison, ABT has a market cap of 233.9B. Regarding current trading prices, BBLGW is priced at $15.00, while ABT trades at $134.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BBLGW currently has a P/E ratio of -104.17, whereas ABT's P/E ratio is 17.48. In terms of profitability, BBLGW's ROE is -2.28%, compared to ABT's ROE of +0.31%. Regarding short-term risk, BBLGW is less volatile compared to ABT. This indicates potentially lower risk in terms of short-term price fluctuations for BBLGW.

Stock Price Comparison

Loading...

Frequently Asked Questions

;